Washington, D.C.
Rachel regularly advises clients on the applicability of federal and state laws governing internet gambling, sports-betting, fantasy sports and other forms of gambling and non-gambling gaming. She has experience preparing gaming license applications in over a dozen states for individuals and entities involved in sports wagering, internet gaming and advance deposit wagering industries. She also has represented non-gambling gaming companies in consumer class action litigations and arbitrations implicating gambling considerations. She counsels clients on the “gamification” of their non-gaming products and services, including NFTs and other blockchain technologies, and advises with respect to the laws governing contests, sweepstakes, and other types of promotions.
Before joining Orrick, Rachel was an associate at another global law firm. She also has experience counseling clients on trade controls, including CFIUS, sanctions and export controls, and responding to congressional investigations.
New York
Before joining Orrick, Brad worked as U.S. regulatory counsel for a major on-line gaming company, during which he facilitated expansion of the U.S. operations, negotiated multiple market-access agreements and oversaw licensing and compliance functions across multiple jurisdictions.
Prior to his private sector experience, Brad was a regulator with the New York State Gaming Commission, Deputy County Executive for Albany (N.Y.) County and Legislative Counsel to the Hon. Eric Adams and other elected officials in the New York State Senate. During his time at the New York State Gaming Commission, Brad was director of interactive fantasy sports and legal counsel on commercial gaming issues, after having served a key role in the selection and vetting of applicants for multiple “Las Vegas” style resort casinos licenses. While in the New York State Senate, Brad served as Counsel to the Senate Committee on Racing, Gaming and Wagering and developed a depth of experience with legislative issues facing the gaming, equine industries and state-run lotteries.
Brad is a graduate of Indiana University-Bloomington School of Law and Union College, where he received a B.A. in Political Science.
Washington, D.C.
Rachel regularly advises clients on the applicability of federal and state laws governing internet gambling, sports-betting, fantasy sports and other forms of gambling and non-gambling gaming. She has experience preparing gaming license applications in over a dozen states for individuals and entities involved in sports wagering, internet gaming and advance deposit wagering industries. She also has represented non-gambling gaming companies in consumer class action litigations and arbitrations implicating gambling considerations. She counsels clients on the “gamification” of their non-gaming products and services, including NFTs and other blockchain technologies, and advises with respect to the laws governing contests, sweepstakes, and other types of promotions.
Before joining Orrick, Rachel was an associate at another global law firm. She also has experience counseling clients on trade controls, including CFIUS, sanctions and export controls, and responding to congressional investigations.
New York
Before joining Orrick, Brad worked as U.S. regulatory counsel for a major on-line gaming company, during which he facilitated expansion of the U.S. operations, negotiated multiple market-access agreements and oversaw licensing and compliance functions across multiple jurisdictions.
Prior to his private sector experience, Brad was a regulator with the New York State Gaming Commission, Deputy County Executive for Albany (N.Y.) County and Legislative Counsel to the Hon. Eric Adams and other elected officials in the New York State Senate. During his time at the New York State Gaming Commission, Brad was director of interactive fantasy sports and legal counsel on commercial gaming issues, after having served a key role in the selection and vetting of applicants for multiple “Las Vegas” style resort casinos licenses. While in the New York State Senate, Brad served as Counsel to the Senate Committee on Racing, Gaming and Wagering and developed a depth of experience with legislative issues facing the gaming, equine industries and state-run lotteries.
Brad is a graduate of Indiana University-Bloomington School of Law and Union College, where he received a B.A. in Political Science.
Washington, D.C.
Washington, D.C.
Sarah advises on legal, legislative, and regulatory matters for a coalition of major online gaming operators. She helps clients structure products and business operations to comply with evolving gaming laws and regulations, and conducts diligence on gaming issues in relation to mergers and acquisitions.
Before joining Orrick, Sarah led the team responsible for providing legal analysis of gaming regulatory matters and products in development at one of the largest online gaming operators in the country. She worked across business units to respond to regulatory inquiries and operational incidents.
Prior to that role Sarah worked on the government affairs team of the operator, advocating for reasonable legal frameworks to govern sports betting, fantasy sports and igaming at a time of unprecedented industry change and growth. She drafted proposed legislation and regulations, testified to legislators, and met with regulators and policymakers as they considered and implemented these frameworks.
Sarah also has previous private practice experience advising online gaming and e-commerce clients in regulatory, transactional and litigation matters.
Washington, D.C.
Washington, D.C.
Sarah advises on legal, legislative, and regulatory matters for a coalition of major online gaming operators. She helps clients structure products and business operations to comply with evolving gaming laws and regulations, and conducts diligence on gaming issues in relation to mergers and acquisitions.
Before joining Orrick, Sarah led the team responsible for providing legal analysis of gaming regulatory matters and products in development at one of the largest online gaming operators in the country. She worked across business units to respond to regulatory inquiries and operational incidents.
Prior to that role Sarah worked on the government affairs team of the operator, advocating for reasonable legal frameworks to govern sports betting, fantasy sports and igaming at a time of unprecedented industry change and growth. She drafted proposed legislation and regulations, testified to legislators, and met with regulators and policymakers as they considered and implemented these frameworks.
Sarah also has previous private practice experience advising online gaming and e-commerce clients in regulatory, transactional and litigation matters.
Washington, D.C.; Boston; New York
Washington, D.C.; Boston; New York
Tony regularly advises on mergers and acquisitions (M&A), private equity, growth equity, and venture capital transactions, as well as on corporate governance, joint ventures and corporate finance matters.
Tony has been recognized for his life sciences and M&A work by a number of notable publications, including The Legal 500 US, Law360, IFLR1000 and Legal Media Group. In particular, Law360 highlighted his work in navigating the complex life sciences industry and key partnership negotiations between biotechnology and drug companies.
In addition, Tony sustains an active pro bono practice, serving as counsel to nonprofit organizations such as Aequitas, APAI Vote, Chefs Stopping Asian American Hate, Rebuilding Together Philadelphia, the Philadelphia Film Society, and the Harvard Asian American Alumni Alliance. Tony also serves as an adjunct professor at Georgetown Law School where he has taught Takeovers, Mergers and Acquisitions since 2015.
Washington, D.C.; Boston; New York
Washington, D.C.; Boston; New York
Tony regularly advises on mergers and acquisitions (M&A), private equity, growth equity, and venture capital transactions, as well as on corporate governance, joint ventures and corporate finance matters.
Tony has been recognized for his life sciences and M&A work by a number of notable publications, including The Legal 500 US, Law360, IFLR1000 and Legal Media Group. In particular, Law360 highlighted his work in navigating the complex life sciences industry and key partnership negotiations between biotechnology and drug companies.
In addition, Tony sustains an active pro bono practice, serving as counsel to nonprofit organizations such as Aequitas, APAI Vote, Chefs Stopping Asian American Hate, Rebuilding Together Philadelphia, the Philadelphia Film Society, and the Harvard Asian American Alumni Alliance. Tony also serves as an adjunct professor at Georgetown Law School where he has taught Takeovers, Mergers and Acquisitions since 2015.
Santa Monica
Sherry’s clients include banks, mortgage originators and servicers, mortgage brokers, commercial lenders, bank holding companies, private equity firms, investment advisors, investment managers, finance companies, fintechs, consumer reporting agencies, data brokers, debt collection companies and related service providers.
She is a Certified Information Privacy Professional (CIPP/US), and was a member of the Mortgage Bankers Association’s 2016 class of Future Leaders and the California Mortgage Bankers Association’s 2014 class of Future Leaders.
Prior to joining Orrick, Sherry was a partner at Buckley LLP. She has been an associate in private practice. She also clerked for the Honorable Jeanette J. Clark in the Superior Court of the District of Columbia.
Santa Monica
Sherry’s clients include banks, mortgage originators and servicers, mortgage brokers, commercial lenders, bank holding companies, private equity firms, investment advisors, investment managers, finance companies, fintechs, consumer reporting agencies, data brokers, debt collection companies and related service providers.
She is a Certified Information Privacy Professional (CIPP/US), and was a member of the Mortgage Bankers Association’s 2016 class of Future Leaders and the California Mortgage Bankers Association’s 2014 class of Future Leaders.
Prior to joining Orrick, Sherry was a partner at Buckley LLP. She has been an associate in private practice. She also clerked for the Honorable Jeanette J. Clark in the Superior Court of the District of Columbia.
Silicon Valley
Michael applies his broad experience in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions to each engagement. He has undertaken over 300 venture capital financings raising an estimated $7 billion for his clients, recently assisting Auris Health to raise over $650 million in financings before its sale to J&J for up to $5.75 billion.
He also brings extensive experience negotiating strategic alliances, representing clients in significant collaborations with GSK, Amgen, Schering-Plough, J&J, Daiichi, Astellas, King Pharmaceuticals, and most recently Pfizer, Merck, Baxter and Dainippon Sumitomo Pharma Co., Ltd.
Michael was the lead lawyer on the initial public offerings for Illumina, Neurocrine Biosciences, Cytokinetics, Pain Therapeutics, NeurogesX, Sequana Therapeutics, Ciphergen Biosystems, Argonaut Technologies, and Microcide Pharmaceuticals.
Michael was also the lead lawyer responsible for negotiating many notable biopharmaceutical spin-outs, including Onyx Pharmaceuticals (Chiron-Cetus), Tularik (Genentech), X-Ceptor (Ligand Pharmaceuticals), Metabasis (Gensia Sicor), and as well on the reverse merger of Transcept Pharmaceuticals with Novacea, creating a new publicly traded entity.
Silicon Valley
Michael applies his broad experience in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions to each engagement. He has undertaken over 300 venture capital financings raising an estimated $7 billion for his clients, recently assisting Auris Health to raise over $650 million in financings before its sale to J&J for up to $5.75 billion.
He also brings extensive experience negotiating strategic alliances, representing clients in significant collaborations with GSK, Amgen, Schering-Plough, J&J, Daiichi, Astellas, King Pharmaceuticals, and most recently Pfizer, Merck, Baxter and Dainippon Sumitomo Pharma Co., Ltd.
Michael was the lead lawyer on the initial public offerings for Illumina, Neurocrine Biosciences, Cytokinetics, Pain Therapeutics, NeurogesX, Sequana Therapeutics, Ciphergen Biosystems, Argonaut Technologies, and Microcide Pharmaceuticals.
Michael was also the lead lawyer responsible for negotiating many notable biopharmaceutical spin-outs, including Onyx Pharmaceuticals (Chiron-Cetus), Tularik (Genentech), X-Ceptor (Ligand Pharmaceuticals), Metabasis (Gensia Sicor), and as well on the reverse merger of Transcept Pharmaceuticals with Novacea, creating a new publicly traded entity.